• ISSN 1674-8301
  • CN 32-1810/R
Turn off MathJax
Article Contents
Brianna Lide, Shane McGuire, Hong Liu, Cristina Chandler. Mast cell activation syndrome—anesthetic challenges in two different clinical scenarios[J]. The Journal of Biomedical Research. doi: 10.7555/JBR.36.20220071
Citation: Brianna Lide, Shane McGuire, Hong Liu, Cristina Chandler. Mast cell activation syndrome—anesthetic challenges in two different clinical scenarios[J]. The Journal of Biomedical Research. doi: 10.7555/JBR.36.20220071

Mast cell activation syndrome—anesthetic challenges in two different clinical scenarios

doi: 10.7555/JBR.36.20220071
More Information
  • Corresponding author: Cristina Chandler and Hong Liu, Department of Anesthesiology and Pain Medicine, University of California Davis Health, 4150 V Street, Suite 1200, Sacramento, CA 95817, USA. Tel/Fax: +1-916-734-5031/+1-916-734-7980, E-mails: cmchandler@ucdavis.edu and hualiu@ucdavis.edu; 
  • Received: 2022-04-02
  • Revised: 2022-04-25
  • Accepted: 2022-04-28
  • Published: 2022-05-28
  • Mast cell activation syndrome (MCAS) includes a group of disorders that result in the inappropriate release of inflammatory mediators from mast cells. These mediators can affect multiple organ systems and lead to significant morbidity, and possible fatality. Although reactions, typically in response to various nonspecific stimuli, are usually mild, they may put those with MCAS at increased risk of anaphylaxis. In this case report, we present two clinical scenarios of MCAS, and identify possible factors triggering mast cell mediator release. We also define a preoperative preventive pathway, outline anesthetic considerations, and discuss the management of immediate hypersensitivity reactions in patients with MCAS. Meticulous preoperative preparation, avoidance of triggers, and development of a plan to treat possible adverse organ responses are paramount of good outcomes.

     

  • loading
  • [1]
    Weiler CR, Austen KF, Akin C, et al. AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management[J]. J Allergy Clin Immunol, 2019, 144(4): 883–896. doi: 10.1016/j.jaci.2019.08.023
    [2]
    Valent P, Akin C, Arock M, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal[J]. Int Arch Allergy Immunol, 2012, 157(3): 215–225. doi: 10.1159/000328760
    [3]
    Valent P, Akin C, Nedoszytko B, et al. Diagnosis, classification and management of mast cell activation syndromes (MCAS) in the era of personalized medicine[J]. Int J Mol Sci, 2020, 21(23): 9030. doi: 10.3390/ijms21239030
    [4]
    Petra AI, Panagiotidou S, Stewart JM, et al. Spectrum of mast cell activation disorders[J]. Expert Rev Clin Immunol, 2014, 10(6): 729–739. doi: 10.1586/1744666X.2014.906302
    [5]
    Bonadonna P, Pagani M, Aberer W, et al. Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper[J]. Allergy, 2015, 70(7): 755–763. doi: 10.1111/all.12617
    [6]
    Di Leo E, Donne PD, Calogiuri GF, et al. Focus on the agents most frequently responsible for perioperative anaphylaxis[J]. Clin Mol Allergy, 2018, 16: 16. doi: 10.1186/s12948-018-0094-7
    [7]
    Blunk JA, Schmelz M, Zeck S, et al. Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin[J]. Anesth Analg, 2004, 98(2): 364–370. doi: 10.1213/01.ANE.0000097168.32472.0D
    [8]
    Matito A, Morgado JM, Sánchez-López P, et al. Management of anesthesia in adult and pediatric mastocytosis: a study of the spanish network on mastocytosis (REMA) based on 726 anesthetic procedures[J]. Int Arch Allergy Immunol, 2015, 167(1): 47–56. doi: 10.1159/000436969
    [9]
    By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American geriatrics society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults[J]. J Am Geriatr Soc, 2019, 67(4): 674–694. doi: 10.1111/jgs.15767
    [10]
    Hermans MAW, Arends NJT, van Wijk RG, et al. Management around invasive procedures in mastocytosis: an update[J]. Ann Allergy Asthma Immunol, 2017, 119(4): 304–309. doi: 10.1016/j.anai.2017.07.022
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(1)

    Article Metrics

    Article views (683) PDF downloads(35) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return